Brief: Cipher Pharmaceuticals Q4 net loss $11.3 million

Cipher Pharmaceuticals

02/03/2017 12:00

March 2 (Reuters) - Cipher Pharmaceuticals Inc  CPH.TO  
    * Cipher Pharmaceuticals reports 2016 Q4 & year-end 
financial results 
    * Cipher Pharmaceuticals Inc qtrly total revenue of $10.7 
million, an increase of 10% from $9.7 million in Q4 2015 
    * Cipher Pharmaceuticals Inc qtrly net loss of $11.3 
million, or $0.45 per basic share 
    * Cipher Pharmaceuticals Inc says "we continue to pursue 
strategic options for U.S. business" 
    * Cipher Pharmaceuticals says have taken steps to reduce 
cost structure; expect to achieve cash savings of about  $3 
million on annualized basis 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nCNWtm1zVa 
Further company coverage:  CPH.TO  
 
 ((bangalore.newsroom@thomsonreuters.com;))